Rehan Verjee
Independent DirectorMr. Rehan Verjee He serves as the Co-Founder, Chief Executive Officer, President, Treasurer, Secretary and Director of Precede Biosciences. Mr. Verjee has been an Independent Director of Tyra Biosciences, Inc. since June 2021. Mr. Verjee served as the Chief Marketing and Strategy Officer at Merck Serono S.A. Mr. Verjee had been President and Global Head of the Innovative Medicine Franchises at EMD Serono, Inc. from August 31, 2018 to 2021. Mr. Verjee had been the Chief Marketing & Strategy Officer for Merck Healthcare at Merck KGaA since September 30, 2015 and served as its General Manager of Canada until September 30, 2015. Mr. Verjee is in charge of the business' global specialty franchises of Oncology, Neurology and Immunology, Fertility and Medical Devices as well as the global immuno-oncology alliance with Pfizer and various strategic functions including Business Development. Mr. Verjee is a Member of The Board of Directors of the Massachusetts Biotechnology Council and of Precede Biosciences. Mr. Verjee holds a Master's in Molecular and Cellular Biochemistry from the University of Oxford in the U.K.
Positions
- Company NameTyra Biosciences, Inc.Stock CodeTYRAPositionIndependent DirectorColleagues
- THTodd HarrisCo-Founder, CEO, President & Director
- BABhavesh AsharChief Operating Officer
- DWDouglas WarnerChief Medical Officer
- DBDaniel BensenCo-Founder & Chief Discovery Officer
- AFAlan FuhrmanChief Financial Officer
- RJRobert J. MoreIndependent Director
- SMSusan MoranIndependent Director
- JSJake SimsonIndependent Director
